Source: National MS Society
December 2012
MS
research continued to advance on many fronts in 2012. This year saw:
research continued to advance on many fronts in 2012. This year saw:
- The approval of a second oral therapy for relapsing forms of MS and
other emerging treatments progressing through the development pipeline; - The launch of the International Progressive MS Collaborative, the largest
effort to date to speed research to stop progressive forms of MS; - The discovery of what could be a target of the immune attack in people with MS,
which may lead to new understanding of the disease and new treatment
strategies; - The completion of the first human
trial of an experimental therapy targeting myelin repair; - Progress in restoring functions
using innovative rehabilitation techniques, including memory enhancement using a technique involving
stories and imagery to solidify learning, and improving balance and mobility with specific exercises; and - Advances in uncovering MS triggering
factors, bringing us closer to finding ways to prevent the disease; and
many other advances pushing us closer to a world free of MS.
In the
world’s largest meeting dedicated to MS research, over 7,000 scientists
convened in Lyon, France to present findings at ECTRIMS (European Committee for
Treatment and Research in MS). Over 1250 studies covering virtually every
aspect of research were presented:
world’s largest meeting dedicated to MS research, over 7,000 scientists
convened in Lyon, France to present findings at ECTRIMS (European Committee for
Treatment and Research in MS). Over 1250 studies covering virtually every
aspect of research were presented:
..
If you would like, you can comment to our blog posts
LIKE this Blog by clicking the LIKE button – top left
REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org to register
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews